Biolargo, Inc. SEC filings BLGO

Biolargo, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 29, 2005. Its latest annual report, Form 10-K, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Biolargo, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
DEF 14A Proxy statement Oct 19, 2026 Dec 1, 2026
8-K/A Amended current report
Regulation FD disclosure
Sep 14, 2026 Sep 10, 2026
8-K Current report
Regulation FD disclosure
Sep 11, 2026 Sep 10, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 6, 2026 May 5, 2026
8-K Current report
Regulation FD disclosure
May 4, 2026 May 4, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
424B4 Prospectus Apr 17, 2026 —
424B4 Prospectus Apr 17, 2026 —
EFFECT Filing Apr 15, 2026 —
EFFECT Filing Apr 15, 2026 —
CORRESP Letter to the SEC Apr 13, 2026 —
CORRESP Letter to the SEC Apr 13, 2026 —
UPLOAD Letter from the SEC Apr 10, 2026 —
UPLOAD Letter from the SEC Apr 10, 2026 —
S-1 Registration statement Apr 9, 2026 —
S-1 Registration statement Apr 9, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Mar 25, 2026 Mar 20, 2026
8-K Current report
Regulation FD disclosure
Mar 5, 2026 Mar 5, 2026
10-K Annual report Mar 4, 2026 Dec 31, 2025
8-K Current report
Other events
Nov 18, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 14, 2025 Nov 14, 2025
8-K Current report
Regulation FD disclosure
Oct 20, 2025 Oct 20, 2025
8-K Current report
Agreement ended, Impairment, Regulation FD disclosure
Sep 25, 2025 Sep 19, 2025
8-K Current report
Regulation FD disclosure
Aug 15, 2025 Aug 15, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Jul 23, 2025 Jul 23, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 19, 2025
424B4 Prospectus Jun 11, 2025 —
EFFECT Filing Jun 9, 2025 —
POS AM Form pos am Jun 5, 2025 —
8-K Current report
Regulation FD disclosure
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
POS AM Form pos am May 14, 2025 —
424B4 Prospectus Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 19, 2025
EFFECT Filing Apr 24, 2025 —
POS AM Form pos am Apr 18, 2025 —
PRE 14A Preliminary proxy statement Apr 10, 2025 Jun 19, 2025
8-K Current report
Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Nov 15, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Aug 15, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
Jun 20, 2024 Jun 13, 2024
8-K Current report
Regulation FD disclosure
Jun 13, 2024 Jun 13, 2024
8-K Current report
Regulation FD disclosure
May 15, 2024 May 14, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
424B4 Prospectus Apr 25, 2024 —
424B4 Prospectus Apr 25, 2024 —
424B4 Prospectus Apr 25, 2024 —
EFFECT Filing Apr 23, 2024 —
EFFECT Filing Apr 23, 2024 —
EFFECT Filing Apr 23, 2024 —
CORRESP Letter to the SEC Apr 19, 2024 —
UPLOAD Letter from the SEC Apr 18, 2024 —
POS EX Form pos ex Apr 15, 2024 —
POS EX Form pos ex Apr 15, 2024 —
S-1 Registration statement Apr 12, 2024 —
POS AM Form pos am Apr 12, 2024 —
POS AM Form pos am Apr 12, 2024 —
RW Form rw Apr 5, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
D Filing Jan 23, 2024 —
8-K Current report
Regulation FD disclosure
Jan 22, 2024 Jan 22, 2024
8-K Current report
Regulation FD disclosure
Jan 10, 2024 Jan 10, 2024
8-K Current report
Auditor change
Jan 5, 2024 Jan 2, 2024
8-K Current report
Regulation FD disclosure
Nov 21, 2023 Nov 20, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Oct 4, 2023 Oct 4, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 12, 2023 Jun 6, 2023
8-K Current report
Regulation FD disclosure
Jun 9, 2023 Jun 6, 2023
8-K Current report
Regulation FD disclosure
Jun 6, 2023 Jun 6, 2023
424B4 Prospectus May 23, 2023 —
8-K Current report
Regulation FD disclosure
May 18, 2023 May 18, 2023
10-Q Quarterly report May 17, 2023 Mar 31, 2023
NT 10-Q Form nt 10-q May 16, 2023 Mar 31, 2023
EFFECT Filing May 10, 2023 —
POS EX Form pos ex May 9, 2023 —
8-K Current report
Regulation FD disclosure
May 9, 2023 May 2, 2023
S-1 Registration statement Apr 27, 2023 —
POS AM Form pos am Apr 27, 2023 —
424B4 Prospectus Apr 24, 2023 —
DEF 14A Proxy statement Apr 21, 2023 Jun 6, 2023
EFFECT Filing Apr 19, 2023 —
POS AM Form pos am Apr 14, 2023 —
8-K Current report
Regulation FD disclosure
Apr 4, 2023 Apr 3, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Material agreement
Mar 27, 2023 Mar 21, 2023
8-K Current report
Regulation FD disclosure
Mar 20, 2023 Mar 20, 2023
424B4 Prospectus Jan 26, 2023 —
EFFECT Filing Jan 19, 2023 —
CORRESP Letter to the SEC Jan 17, 2023 —
S-1/A Amended registration statement Jan 11, 2023 —
CORRESP Letter to the SEC Jan 6, 2023 —
CORRESP Letter to the SEC Jan 4, 2023 —
UPLOAD Letter from the SEC Jan 3, 2023 —
S-1 Registration statement Dec 23, 2022 —
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2022 Dec 13, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 3, 2022 Nov 1, 2022
8-K Current report
Regulation FD disclosure
Oct 31, 2022 Oct 26, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Regulation FD disclosure
Aug 5, 2022 Aug 3, 2022
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 7, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure
Jun 2, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure
May 19, 2022 May 17, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
D Filing May 4, 2022 —
424B4 Prospectus Apr 22, 2022 —
424B4 Prospectus Apr 22, 2022 —
424B4 Prospectus Apr 22, 2022 —
8-K Current report
Regulation FD disclosure
Apr 20, 2022 Apr 20, 2022
EFFECT Filing Apr 19, 2022 —
EFFECT Filing Apr 19, 2022 —
EFFECT Filing Apr 19, 2022 —
DEF 14A Proxy statement Apr 18, 2022 Jun 2, 2022
POS AM Filing Apr 14, 2022 —
POS AM Filing Apr 14, 2022 —
POS AM Filing Apr 14, 2022 —
PRE 14A Preliminary proxy statement Apr 4, 2022 Apr 4, 2022
8-K Current report
Regulation FD disclosure
Apr 4, 2022 Mar 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Material agreement
Mar 24, 2022 Mar 22, 2022
8-K Current report
Material agreement
Mar 8, 2022 Mar 3, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 17, 2021 Jun 15, 2021
8-K Current report
Regulation FD disclosure
Jun 15, 2021 Jun 15, 2021
8-K Current report
Other events
May 19, 2021 May 17, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 22, 2021 Jun 15, 2021
424B4 Prospectus Apr 13, 2021 —
424B4 Prospectus Apr 12, 2021 —
424B4 Prospectus Apr 12, 2021 —
424B4 Prospectus Apr 12, 2021 —
EFFECT Filing Apr 8, 2021 —
EFFECT Filing Apr 8, 2021 —
EFFECT Filing Apr 8, 2021 —
EFFECT Filing Apr 8, 2021 —
POS AM Form pos am Apr 8, 2021 —
POS AM Form pos am Apr 7, 2021 —
POS AM Form pos am Apr 7, 2021 —
POS AM Form pos am Apr 7, 2021 —
PRE 14A Preliminary proxy statement Apr 2, 2021 Apr 1, 2021
8-K Current report
Regulation FD disclosure
Mar 31, 2021 Mar 30, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
8-K Current report
Material agreement
Mar 19, 2021 Mar 18, 2021
8-K Current report
Other events
Mar 5, 2021 Mar 1, 2021
8-K Current report
Regulation FD disclosure
Jan 25, 2021 Jan 25, 2021
8-K Current report
Regulation FD disclosure
Dec 21, 2020 Dec 21, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
8-K Current report
Unregistered share sale, Regulation FD disclosure
Aug 4, 2020 Aug 4, 2020
8-K Current report
Shareholder vote results
Jul 28, 2020 Jul 23, 2020
DEFA14A Additional proxy material Jul 20, 2020 —
8-K Current report
Material agreement
Jul 7, 2020 Jun 30, 2020
UPLOAD Letter from the SEC May 28, 2020 —
DEF 14A Proxy statement May 27, 2020 Jul 23, 2020
10-Q Quarterly report May 19, 2020 Mar 31, 2020
NT 10-Q/A Form nt 10-q/a May 18, 2020 Mar 31, 2020
NT 10-K Form nt 10-k May 15, 2020 Mar 31, 2020
PRER14A Form prer14a May 7, 2020 —
424B4 Prospectus Apr 30, 2020 —
424B4 Prospectus Apr 30, 2020 —
424B4 Prospectus Apr 30, 2020 —
EFFECT Filing Apr 28, 2020 —
EFFECT Filing Apr 28, 2020 —
EFFECT Filing Apr 28, 2020 —
PRE 14A Preliminary proxy statement Apr 28, 2020 Jul 23, 2020
POS AM Form pos am Apr 28, 2020 —
POS AM Form pos am Apr 28, 2020 —
POS AM Form pos am Apr 27, 2020 —
EFFECT Filing Apr 21, 2020 —
424B4 Prospectus Apr 21, 2020 —
DEL AM Form del am Apr 16, 2020 —
S-1 Registration statement Apr 10, 2020 —
8-K Current report
Regulation FD disclosure
Mar 31, 2020 Mar 31, 2020
10-K Annual report Mar 31, 2020 Dec 31, 2019
8-K Current report
Material agreement
Mar 31, 2020 Mar 30, 2020
NT 10-K Form nt 10-k Mar 30, 2020 Dec 31, 2019
8-K Current report
Regulation FD disclosure
Mar 23, 2020 Mar 20, 2020
8-K Current report
Regulation FD disclosure
Mar 3, 2020 Mar 3, 2020
8-K Current report
Material agreement
Feb 27, 2020 Feb 25, 2020
8-K Current report
Regulation FD disclosure
Feb 12, 2020 Feb 12, 2020
SEC ACTION Filing Dec 9, 2019 —
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
424B4 Prospectus Oct 2, 2019 —
EFFECT Filing Sep 30, 2019 —
CORRESP Letter to the SEC Sep 23, 2019 —
8-K Current report
Regulation FD disclosure
Sep 23, 2019 Sep 23, 2019
EFFECT Filing Sep 20, 2019 —
424B4 Prospectus Sep 20, 2019 —
UPLOAD Letter from the SEC Sep 19, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Chemicals & Allied Products (SIC 2800)
Listed as
BLGO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westminster, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
880242
Former names
NUWAY MEDICAL INC (until Apr 3, 2007); NUWAY ENERGY INC (until Feb 5, 2003); LATIN AMERICAN CASINOS INC (until Feb 15, 2001)

Other Chemicals & Allied Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.